Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Becton Dickinson and Company is a medical instruments & supplies business based in the US. Becton Dickinson and Company shares (BDX) are listed on the NYSE and all prices are listed in US Dollars. Becton Dickinson and Company employs 75,000 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $264.63 |
|---|---|
| 52-week range | $233.63 - $264.50 |
| 50-day moving average | $249.31 |
| 200-day moving average | $248.08 |
| Wall St. target price | $270.23 |
| PE ratio | 38.3387 |
| Dividend yield | $3.32 (1.33%) |
| Earnings per share (TTM) | $6.85 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $264.63 from 2022-01-21
| 1 week (2022-01-13) | 0.36% |
|---|---|
| 1 month (2021-12-18) | N/A |
| 3 months (2021-10-18) | N/A |
| 6 months (2021-07-22) | 6.13% |
| 1 year (2021-01-22) | 2.27% |
|---|---|
| 2 years (2020-01-22) | -5.09% |
| 3 years (2019-01-22) | 10.64% |
| 5 years (2017-01-20) | 53.60% |
Valuing Becton Dickinson and Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Becton Dickinson and Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Becton Dickinson and Company's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 38x. In other words, Becton Dickinson and Company shares trade at around 38x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Becton Dickinson and Company's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.7837. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Becton Dickinson and Company's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Becton Dickinson and Company's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $5.6 billion.
The EBITDA is a measure of a Becton Dickinson and Company's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $20.2 billion |
|---|---|
| Operating margin TTM | 16.64% |
| Gross profit TTM | $9.6 billion |
| Return on assets TTM | 3.9% |
| Return on equity TTM | 8.82% |
| Profit margin | 10.33% |
| Book value | $83.22 |
| Market capitalisation | $74.9 billion |
TTM: trailing 12 months
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Becton Dickinson and Company.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 33.76
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Becton Dickinson and Company's overall score of 33.76 (as at 12/31/2018) is pretty weak – landing it in it in the 65th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Becton Dickinson and Company is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 4.87/100
Becton Dickinson and Company's environmental score of 4.87 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Becton Dickinson and Company is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 20.06/100
Becton Dickinson and Company's social score of 20.06 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Becton Dickinson and Company is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 13.83/100
Becton Dickinson and Company's governance score puts it squarely in the 5th percentile of companies rated in the same sector. That could suggest that Becton Dickinson and Company is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Becton Dickinson and Company scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Becton Dickinson and Company hasn't always managed to keep its nose clean.
Becton Dickinson and Company was last rated for ESG on: 2019-01-01.
| Total ESG score | 33.76 |
|---|---|
| Total ESG percentile | 65.34 |
| Environmental score | 4.87 |
| Environmental score percentile | 5 |
| Social score | 20.06 |
| Social score percentile | 5 |
| Governance score | 13.83 |
| Governance score percentile | 5 |
| Level of controversy | 3 |
Dividend payout ratio: 25.71% of net profits
Recently Becton Dickinson and Company has paid out, on average, around 25.71% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.33% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Becton Dickinson and Company shareholders could enjoy a 1.33% return on their shares, in the form of dividend payments. In Becton Dickinson and Company's case, that would currently equate to about $3.32 per share.
While Becton Dickinson and Company's payout ratio might seem fairly standard, it's worth remembering that Becton Dickinson and Company may be investing much of the rest of its net profits in future growth.
Becton Dickinson and Company's most recent dividend payout was on 30 December 2021. The latest dividend was paid out to all shareholders who bought their shares by 8 December 2021 (the "ex-dividend date").
Becton Dickinson and Company's shares were split on a 2:1 basis on 20 August 1998. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Becton Dickinson and Company shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Becton Dickinson and Company shares which in turn could have impacted Becton Dickinson and Company's share price.
Over the last 12 months, Becton Dickinson and Company's shares have ranged in value from as little as $233.6274 up to $264.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Becton Dickinson and Company's is 0.7217. This would suggest that Becton Dickinson and Company's shares are less volatile than average (for this exchange).
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey. .
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Read our expert analysis on Vigorus and how the token will perform in the future.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut earns up to 10% APY, but you must have an iOS device.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.